AMERICAN CENTURY COMPANIES INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$26,631,000
+120.6%
391,051
+3.5%
0.02%
+130.0%
Q2 2022$12,073,000
-1.1%
377,862
+7.2%
0.01%
+25.0%
Q1 2022$12,204,000
+17.9%
352,335
-0.4%
0.01%
+14.3%
Q4 2021$10,354,000
+18.8%
353,745
+3.4%
0.01%
+16.7%
Q3 2021$8,715,000
-27.3%
342,025
-0.1%
0.01%
-25.0%
Q2 2021$11,989,000
+41.7%
342,356
+64.9%
0.01%
+33.3%
Q1 2021$8,463,000
+52.9%
207,672
+62.5%
0.01%
+50.0%
Q4 2020$5,534,000
+17.6%
127,785
+49.8%
0.00%0.0%
Q3 2020$4,705,000
-21.1%
85,326
-9.7%
0.00%
-33.3%
Q2 2020$5,964,000
+15.8%
94,467
-6.3%
0.01%0.0%
Q1 2020$5,152,000
-38.9%
100,834
-4.9%
0.01%
-25.0%
Q4 2019$8,429,000
+166.0%
106,033
+62.3%
0.01%
+166.7%
Q3 2019$3,169,000
-2.0%
65,318
+6.3%
0.00%0.0%
Q2 2019$3,233,000
+29.5%
61,472
+30.3%
0.00%0.0%
Q1 2019$2,497,000
+8.8%
47,179
-15.7%
0.00%0.0%
Q4 2018$2,296,000
+2.6%
55,941
-5.0%
0.00%
+50.0%
Q3 2018$2,238,000
-16.5%
58,882
-0.7%
0.00%
-33.3%
Q2 2018$2,680,00059,3010.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders